CSBR

Champions Oncology, Inc. (CSBR) Porter's 5 Forces Analysis (2026)

Invetso Score: 6.3/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

New Entrants

Score: 7.2 (Strong)

Champions Oncology benefits from high entry barriers due to its proprietary assets, established client relationships, and regulatory requirements, limiting the threat from new entrants.

Supplier Power

Score:

Supplier power is elevated due to the specialized nature and limited availability of key inputs, though the company’s sourcing strategies provide some mitigation.

Buyer Power

Score:

While buyer concentration creates pricing pressure, high switching costs and the need for specialized services partially offset this risk.

Substitutes

Score:

Substitution risk is rising as new technologies mature, but Champions Oncology’s validated models and client trust currently provide a buffer.

Rivalry

Score:

Competitive rivalry remains high due to a fragmented market and ongoing innovation, though Champions Oncology’s differentiated offerings provide some insulation.

Overall Score

Score:

Champions Oncology operates in a structurally attractive niche with high entry barriers and differentiated offerings, but faces elevated risks from supplier concentration, buyer leverage, substitutes, and intense competition. The company’s proprietary assets and client relationships support its position, yet margin and growth resilience depend on continued innovation and operational execution.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Champions Oncology, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →